NATALIE FUSCO: Open Payments
NPI 1780300368 · NEW PROVIDENCE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 12 payments from 8 companies in 2025. Trend: 2023 $453 · 2024 $268 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| AtriCure, Inc. | 2 | $44 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Impulse Dynamics (USA) Inc. | 1 | $24 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $23 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: ATRICLIP LAA EXCLUSION SYSTEM, JARDIANCE, VERQUVO, NEXLETOL, Optimizer, LifeVest, VYNDAQEL, FARXIGA.
Industry payments across NJ — which companies pay providers there.
